|
AGTPBP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.33999997156786E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.25130000028228E-07 |
| Normal-vs-Stage2 |
4.73519999988348E-07 |
| Normal-vs-Stage3 |
1.17899999763083E-08 |
| Normal-vs-Stage4 |
9.51480000010996E-07 |
| Stage1-vs-Stage2 |
2.033800E-01 |
| Stage1-vs-Stage3 |
1.006760E-01 |
| Stage1-vs-Stage4 |
1.906620E-01 |
| Stage2-vs-Stage3 |
9.658200E-01 |
| Stage2-vs-Stage4 |
9.843400E-01 |
| Stage3-vs-Stage4 |
9.478400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.95069999545206E-08 |
| Normal-vs-AfricanAmerican |
2.164400E-04 |
| Normal-vs-Asian |
9.82969999951955E-07 |
| Caucasian-vs-AfricanAmerican |
9.720000E-01 |
| Caucasian-vs-Asian |
6.899000E-01 |
| AfricanAmerican-vs-Asian |
7.403200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.8463999953502E-08 |
| Normal-vs-Female |
5.04529995559722E-09 |
| Male-vs-Female |
9.454800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.52417000000016E-05 |
| Normal-vs-Age(41-60Yrs) |
5.30150368049931E-11 |
| Normal-vs-Age(61-80Yrs) |
1.22470000030184E-07 |
| Normal-vs-Age(81-100Yrs) |
1.023820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.526000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.379200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.488400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.702000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.055800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.238200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.901800E-01 |
| Classical-VS-Follicular |
2.405800E-02 |
| Classical-VS-Other |
4.506000E-01 |
| Classical-VS-Normal |
2.0701000003065E-07 |
| Tall-VS-Follicular |
4.986600E-01 |
| Tall-VS-Other |
6.902600E-01 |
| Tall-VS-Normal |
7.53300000000401E-05 |
| Follicular-VS-Other |
9.852400E-01 |
| Follicular-VS-Normal |
2.99789999491651E-08 |
| Other-VS-Normal |
4.483400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.72869957132593E-10 |
| Normal-vs-N1 |
1.69909999958584E-07 |
| N0-vs-N1 |
8.180400E-01 |
|
|
